Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 633 - 640 of 12007 results

DOJ Issues its Highly Anticipated Whistleblower Awards Pilot Program

August 15, 2024| Blog| Viewpoint

Senate Commerce Committee Advances 10 AI Bills – AI: The Washington Report

August 14, 2024| Article| Viewpoint

PFAS' Regulatory Scrutiny Here to Stay Despite Legal Challenges, Environmental Experts Say

August 14, 2024| News

DOJ Files False Claims Act Suit against Public Health System Alleging Widespread Stark Law Violations for Excessive Physician Compensation

August 13, 2024| Blog| Viewpoint

2024 Pre-Election Analysis: US-Canada Cross-Border Issues

August 12, 2024| Advisory| Viewpoint

FDA and CTTI Hold Joint Workshop on AI in Drug Development – AI: The Washington Report

August 9, 2024| Article| Viewpoint

What Can the Canadian Pension Industry Learn from US CAP Litigation?

August 9, 2024| News

What’s Next? Google Found Liable In Search Monopolization Case with Remedies Phase To Come

August 7, 2024| Blog| Viewpoint

News & Press Releases

Mintz Advises ArriVent BioPharma on $75 Million Underwritten Public Offering

July 08, 2025

Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“

Mintz Advises S2G Investments on $40M Series B Financing of Sojo Industries

July 07, 2025

Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

View all News and Press Releases